Please login to the form below

Not currently logged in
Email:
Password:

Ovid Therapeutics adds member to scientific advisory board

Dr Jerome Zeldis joins the firm
ovid Therapeutics

New York-based Ovid Therapeutics has appointed Dr Jerome Zeldis to its scientific advisory board.

Ovid is a privately-held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain.

Dr Zeldis has been noted for his successful experience in drug development and previously served as Celgene's senior VP of clinical research and medical affairs.

Prior to joining Celgene in 1997, Dr Zeldis was associate director of clinical research at Sandoz Research Institute and director of medical development at Janssen Pharmaceutical Research Institute.

He said: “Ovid is pursuing an ambitious approach of tackling rare neurological diseases with significant unmet needs. With this goal, the company has assembled a world-class leadership and is employing a science-based approach to target new pathways that are involved in these diseases.

“I look forward to working closely with Ovid's team.”

Jeremy Levin, CEO and chairman of Ovid, added: “We are delighted and privileged to welcome Jerry to our scientific advisory board.

“Jerry's advice and insight will be extremely valuable as we enter the clinic.”

12th October 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...